Document is current
Any future updates will be listed below
-
Authors
Ren, Peng
Wang, Ziliang
Liang, Zihui
Xia, Shenglin
Yuan, Xiangnan
Zhou, Fenghua
Liu, Xueyong
-
Funding
Funding for this research was provided by:
Basic Research Program of Liaoning Province (No.2022JH2/101300030)
Shenyang Science and Technology Plan-Public Health Research and Development Special Project (No.21-172-9-07)
- License Information
-
More Information
Article History
Received: 30 May 2024
Accepted: 18 April 2025
First Online: 25 April 2025
Declarations
:
: This study was approved by the Medical Ethics Committee of Shengjing Hospital of China Medical University, Number: 2023PS571 K, and will adhere to the guidelines set forth in the Declaration of Helsinki. The study is also registered with the Chinese Clinical Trial Registry. The results will be showcased at both domestic and global conferences and disseminated through peer-reviewed scientific publications. The participants will provide their informed consent to participate in the study.
: Not applicable, personal and clinical details of participants will not be provided in this study and will not be provided in the reporting of trial results.
: There are no financial and other competing interests for principal investigators for the overall trial.Patient and public involvement.Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.
